AU2002362494A1 - Tumor-peptide antigens from the human prdi-bf1-protein - Google Patents

Tumor-peptide antigens from the human prdi-bf1-protein

Info

Publication number
AU2002362494A1
AU2002362494A1 AU2002362494A AU2002362494A AU2002362494A1 AU 2002362494 A1 AU2002362494 A1 AU 2002362494A1 AU 2002362494 A AU2002362494 A AU 2002362494A AU 2002362494 A AU2002362494 A AU 2002362494A AU 2002362494 A1 AU2002362494 A1 AU 2002362494A1
Authority
AU
Australia
Prior art keywords
prdi
tumor
protein
human
peptide antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002362494A
Other languages
English (en)
Inventor
Carina Lotz
Matthias Theobald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUGENICS AG
Original Assignee
IMMUGENICS AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUGENICS AG filed Critical IMMUGENICS AG
Publication of AU2002362494A1 publication Critical patent/AU2002362494A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002362494A 2001-09-29 2002-09-24 Tumor-peptide antigens from the human prdi-bf1-protein Abandoned AU2002362494A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10148236A DE10148236A1 (de) 2001-09-29 2001-09-29 Tumor-Peptidantigene aus humanem PRDI-BF1-Protein
DE10148236.1 2001-09-29
PCT/EP2002/010701 WO2003029282A2 (de) 2001-09-29 2002-09-24 Tumor-peptidantigene aus humanem prdi-bf1-protein

Publications (1)

Publication Number Publication Date
AU2002362494A1 true AU2002362494A1 (en) 2003-04-14

Family

ID=7700869

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002362494A Abandoned AU2002362494A1 (en) 2001-09-29 2002-09-24 Tumor-peptide antigens from the human prdi-bf1-protein

Country Status (3)

Country Link
AU (1) AU2002362494A1 (de)
DE (1) DE10148236A1 (de)
WO (1) WO2003029282A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831008A (en) * 1994-08-18 1998-11-03 La Jolla Cancer Research Foundation Retinoblastoma protein-interacting zinc finger proteins

Also Published As

Publication number Publication date
WO2003029282A3 (de) 2004-04-01
DE10148236A1 (de) 2003-04-24
WO2003029282A2 (de) 2003-04-10

Similar Documents

Publication Publication Date Title
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU2002310044A1 (en) Headwall
AU2002254558A1 (en) Novel vaccine
AU2002317759A1 (en) Ophthalmoscope
AU2002365649A1 (en) Anti-dota antibody
GB0126378D0 (en) Antigen
AU2002349543A1 (en) Tumor antigens
AU2002307438A1 (en) Cancer-testis antigens
AU2002362494A1 (en) Tumor-peptide antigens from the human prdi-bf1-protein
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AUPR827701A0 (en) The lawn-scaper
AU2001100510A4 (en) The walkers friend
AUPR884901A0 (en) The mirroriad lipstick
GB0112448D0 (en) Antigens
GB0111492D0 (en) Antigens
GB0119479D0 (en) Antigens
AU2002211364A1 (en) Human anti-cd40 antibodies
AUPR545401A0 (en) The cup cup
AU2002100681A4 (en) Improved rotating-wing aircraft
AUPR494201A0 (en) The device
AU2002302785A1 (en) Vaccines
AU2002337263A1 (en) Anti-coronavirus vaccine
AUPR440001A0 (en) Vaccine
AU2001100532A4 (en) FonePark

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase